View more in
Health

Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer

360dx.com
 2021-06-14

NEW YORK – Genecast said on Monday that it will launch a clinical trial to assess whether its qPCR-based liquid biopsy test can detect EGFR mutations in early-stage non-small cell lung cancer, or NSCLC, patients. The Seoul, South Korea-based diagnostics firm developed its liquid biopsy assay using allele-discriminating priming system,...

www.360dx.com

Comments / 0

Comments / 0